Assessing the Impact of EXPAREL(R) on Opioid Use and Patient Reported Outcomes When Administered by Infiltration Into the Transversus Abdominis Plane (TAP) Under Ultrasound Guidance for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2014
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pacira Pharmaceuticals
- 21 Feb 2014 According to the ClinicalTrials.gov record, status changed from recruiting to discontinued.
- 30 Aug 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 12 Aug 2013 New trial record